155206-00-1
155206-00-1 structure
- Name: Bimatoprost
- Chemical Name: bimatoprost
- CAS Number: 155206-00-1
- Molecular Formula: C25H37NO4
- Molecular Weight: 415.566
- Catalog: API Hormone and endocrine-regulating drugs Prostaglandins
- Create Date: 2018-09-22 17:37:20
- Modify Date: 2026-07-01 18:20:39
-
Bimatoprost is a prostaglandin analog used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension.Target: Prostaglandin ReceptorBimatoprost is a prostaglandin analog/prodrug used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. It reduces intraocular pressure (IOP) by increasing the outflow of aqueous fluid from the eyes. In December 2008, the indication to lengthen eyelashes was approved by the U.S. Food and Drug Administration (FDA); the cosmetic formulation of bimatoprost is sold as Latisse. In 2008-2011, at least three case series suggested that bimatoprost has the ability to reduce adipose (fat) tissue.Bimatoprost activates prostamide alpha F2 receptors found in the hair follicle to stimulate its growth rate. Research led by Professor Randall and the University of Bradford found that it may also offer a treatment for scalp hair regrowth in trials conducted on samples taken from men undergoing hair transplants. According to Allergan's package labeling, users of its Latisse cosmetic product didn't develop darker irises in clinical studies; however, "patients should be advised about the potential for increased brown iris pigmentation which is likely to be permanent."
| Name | bimatoprost |
|---|---|
| Synonyms |
BIMATOPROST
(Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(S,E)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl]-N-ethylht-5-enamide Bimatoprost, >= (Z)-7-((1R,2R,3S,5S)-3,5-Dihydroxy-2-((S,E)-3-hydroxy-5-phenylpent-1-enyl)cyclopentyl)-N-ethyl (Z)-7-((1R,2R,3S,5S)-3,5-dihydroxy-2-((E)-3-hydroxy-5-phenylpent-1-enyl)cyclopentyl)-N-ethylht-5-enamide Bimatoprost (W.S) cGMP Bimatoprost Hydroxy-5-Phenylpent-1-Enyl]Cyclopentyl]-N-Ethylht-5 Lumigan Bemrost (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-5-htenamide Bima 17-phenyl-tri-norprostaglandin f2α-ethyl amide Bimatoprost API BIMATOPROST(LUMIGAN) BiMatoprost HOUSE STANDD BIMATOPROST(TM) Bimatoprost-1 (Z)-7-[(1S,2S,3R,5R)-3,5-Dihydroxy-2-[(E)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylht-5-enamide 17-PHENYL TRINOR PROSTAGLANDIN F2ALPHA ETHYL AMIDE bimatopros MFCD03411999 17-Phenyltrinor-PGF2alpha Ethylamide Bisoprostol (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl]-N-ethylht-5-enaMide Bimatoprost, 10 mM in DMSO D5-Bimatoprost BimatoprostQ: What is Bimatoprost Q: What is the CAS Number of Bimatoprost Q: What is the storage condition of Bimatoprost Q: What e the applications of Bimatoprost 17-Phenyl-tri-norprostaglandin F2α-ethyl amide 5-Htenamide, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-, (5Z) bimatoprost powder (Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylht-5-enamide Bimalprostone (5Z)-7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl}-N-ethyl-5-heptenamide 17-phenyl-tri-norprostaglandin f2α-ethyl a (E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3- hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylht-5-enamide 17-Phenyl-tri-norprostaglandin F2a-ethyl aMide (5Z)-7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}-N-ethylhept-5-enamide Prostamide LUMIGAN Bimatoprost Reference Standd buprostaglandin Bimatoprost CAS 155206 00 1 BiMatoprost HOUSE STANDARD BiMapnost N-ETHYL-9ALPHA,11ALPHA,15S-TRIHYDROXY-17-PHENYL-18,19,20-TRINOR-PROSTA-5Z, 13E-DIEN-1-AMIDE Beme Prostaglandin 6-Amino-2,4-dichloro-6-methylphenol&hydrochloride Bimatoprost CAS Bimatoprost CAS NO.155-1 GMP Bimatoprost Bimatoprost //BP |
| Description | Bimatoprost is a prostaglandin analog used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension.Target: Prostaglandin ReceptorBimatoprost is a prostaglandin analog/prodrug used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. It reduces intraocular pressure (IOP) by increasing the outflow of aqueous fluid from the eyes. In December 2008, the indication to lengthen eyelashes was approved by the U.S. Food and Drug Administration (FDA); the cosmetic formulation of bimatoprost is sold as Latisse. In 2008-2011, at least three case series suggested that bimatoprost has the ability to reduce adipose (fat) tissue.Bimatoprost activates prostamide alpha F2 receptors found in the hair follicle to stimulate its growth rate. Research led by Professor Randall and the University of Bradford found that it may also offer a treatment for scalp hair regrowth in trials conducted on samples taken from men undergoing hair transplants. According to Allergan's package labeling, users of its Latisse cosmetic product didn't develop darker irises in clinical studies; however, "patients should be advised about the potential for increased brown iris pigmentation which is likely to be permanent." |
|---|---|
| Related Catalog | |
| References |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 629.8±55.0 °C at 760 mmHg |
| Melting Point | 66-68°C |
| Molecular Formula | C25H37NO4 |
| Molecular Weight | 415.566 |
| Flash Point | 334.7±31.5 °C |
| Exact Mass | 415.272247 |
| PSA | 89.79000 |
| LogP | 1.98 |
| Vapour Pressure | 0.0±1.9 mmHg at 25°C |
| Index of Refraction | 1.591 |
| Storage condition | −20°C |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Hazard Codes | Xi |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| Precursor 8 | |
|---|---|
| DownStream 0 | |
